Ticker | Name | Market cap, $ | Price, $ | Price change, %04 Nov 2024 | Country | PE ratio | PB ratio | PS ratio | Revenue (quarterly), $ | EPS diluted (quarterly), $ |
|---|---|---|---|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | 124.04 B | 480.57 | +2.69 | United States | 8.40 | 12.00 | 2.65 B | -13.92 | ||
| Regeneron Pharmaceuticals | 91.21 B | 830.00 | -1.54 | United States | 20.54 | 3.11 | 6.59 | 3.72 B | 11.54 | |
| argenx SE | 35.20 B | 588.67 | -0.23 | Netherlands | 18.94 | 573.24 M | 1.39 | |||
| Alnylam Pharmaceuticals | 34.82 B | 269.95 | -0.02 | United States | 1.08 K | 16.62 | 500.92 M | -0.87 | ||
| BioNTech SE | 25.80 B | 108.49 | -3.05 | Germany | 1.26 | 8.86 | 138.58 M | -3.62 | ||
| BeiGene | 21.98 B | 207.25 | +1.49 | Cayman Islands | 6.53 | 7.10 | 929.17 M | -1.17 | ||
| Moderna | 20.66 B | 53.75 | -1.84 | United States | 1.76 | 4.14 | 221.00 M | -3.33 | ||
| United Therapeutics | 16.41 B | 367.57 | -1.98 | United States | 16.14 | 2.69 | 5.95 | 748.90 M | 6.39 | |
| Summit Therapeutics | 14.79 B | 20.05 | +5.80 | United States | 33.76 | -0.08 | ||||
| Incyte | 14.59 B | 75.75 | -1.11 | United States | 541.07 | 4.60 | 3.58 | 1.14 B | 0.54 | |
| Genmab A/S | 14.47 B | 22.78 | +0.84 | Denmark | 18.69 | 3.25 | 5.26 | 779.75 M | 0.31 | |
| BioMarin Pharmaceutical | 12.51 B | 65.65 | -0.55 | United States | 39.31 | 2.31 | 4.54 | 745.74 M | 0.55 | |
| Insmed Incorporated | 12.32 B | 68.85 | +3.53 | United States | 25.48 | 35.92 | 93.42 M | -1.27 | ||
| Royalty Pharma | 12.17 B | 27.15 | -0.51 | United States | 18.10 | 1.88 | 5.44 | 537.27 M | 0.23 | |
| Bio-Techne | 12.04 B | 75.90 | +1.31 | United States | 80.74 | 5.63 | 10.28 | 289.46 M | 0.21 | |
Ticker | Name | Market cap, $ | Price, $ | Price change, %04 Nov 2024 | Country | PE ratio | PB ratio | PS ratio | Revenue (quarterly), $ | EPS diluted (quarterly), $ |
On page:
On page: